DPBio is a pioneering biotechnology company based in California, specializing in high-throughput droplet microfluidic technology that drives innovation across life sciences, biotechnology, and drug discovery. By integrating advanced microfluidics with life science applications, DPBio develops comprehensive solutions that include microfluidic chips, instruments, and reagents – enabling precise, efficient, and scalable research workflows.Trusted by leading biopharmaceutical companies, CROs, and top-tier research institutions worldwide, DPBio’s technologies empower scientists in fields such as antibody discovery, enzyme evolution, strain screening, small-molecule drug screening, cancer research, early disease detection, and biopharmaceutical quality control.Founded on microfluidic technology incubated at the Hong Kong University of Science and Technology, DPBio has rapidly evolved into a global innovator recognized for its engineering excellence, product design, and scientific contributions. The company’s dedication to pragmatism, truth-seeking, and innovation continues to shape the future of biomedical research and synthetic biology.As a proud distribution partner of DPBio, Altium International brings their most advanced microfluidic systems to our regional markets, including:OMNIdrop – a precision droplet generation system for uniform assays, reagent mixing, and cell encapsulation.CytoSpark® – a high-throughput microfluidic screening platform capable of analyzing millions of single cells simultaneously, accelerating workflows in antibody discovery and functional screening.Together with DPBio, Altium International delivers next-generation tools that accelerate discovery and enable breakthroughs in life sciences.